Literature DB >> 9368779

HLA class I specific inhibitory receptors.

A Moretta1, L Moretta.   

Abstract

All human natural killer cells and some memory T cells express HLA class I receptors, so-called natural killer cell receptors (NKRs), a receptor class that in the past few years has been shown to include several members of the immunoglobulin superfamily and the C-type lectin CD94-NKG2A complex. NKR ligand mediated cross-linking leads to the recruitment and activation of a tyrosine phosphatase involved in downregulating the phosphorylation of effector molecules involved in cell triggering. Thus, NKR engagement leads to the inhibition of different NK and T cell functions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9368779     DOI: 10.1016/s0952-7915(97)80051-9

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  13 in total

Review 1.  Can we make a better match or mismatch with KIR genotyping?

Authors:  Rohtesh S Mehta; Katayoun Rezvani
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

2.  Activation of human NK cells by staphylococci and lactobacilli requires cell contact-dependent costimulation by autologous monocytes.

Authors:  D Haller; P Serrant; D Granato; E J Schiffrin; S Blum
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

3.  Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype.

Authors:  D F Dukers; M H Vermeer; L H Jaspars; C A Sander; M J Flaig; W Vos; R Willemze; C J Meijer
Journal:  J Clin Pathol       Date:  2001-03       Impact factor: 3.411

4.  Synergy of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I-deficient and MHC I+ tumors.

Authors:  Natalie K Wolf; Cristina Blaj; Lora K Picton; Gail Snyder; Li Zhang; Christopher J Nicolai; Chudi O Ndubaku; Sarah M McWhirter; K Christopher Garcia; David H Raulet
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-19       Impact factor: 12.779

5.  Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas.

Authors:  Anna Kruschinski; Andreas Moosmann; Isabel Poschke; Håkan Norell; Markus Chmielewski; Barbara Seliger; Rolf Kiessling; Thomas Blankenstein; Hinrich Abken; Jehad Charo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-05       Impact factor: 11.205

6.  Rapid improvement of disseminated intravascular coagulation by donor leukocyte infusions in a patient with promyelocytic crisis of chronic myelogenous leukemia after reduced-intensity stem cell transplantation from an HLA 2-antigen-mismatched mother.

Authors:  Kosei Matsue; Konagi Yamada; Masami Takeuchi; Takayuki Tabayashi
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

Review 7.  Transplantation of haploidentically mismatched stem cells for the treatment of malignant diseases.

Authors:  Franco Aversa; Massimo F Martelli
Journal:  Springer Semin Immunopathol       Date:  2004-09-11

8.  Urochordates and the origin of natural killer cells: identification of a CD94/NKR-P1-related receptor in blood cells of Botryllus.

Authors:  Konstantin Khalturin; Matthias Becker; Baruch Rinkevich; Thomas C G Bosch
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-07       Impact factor: 11.205

9.  The tyrosine kinase PYK-2/RAFTK regulates natural killer (NK) cell cytotoxic response, and is translocated and activated upon specific target cell recognition and killing.

Authors:  D Sancho; M Nieto; M Llano; J L Rodríguez-Fernández; R Tejedor; S Avraham; C Cabañas; M López-Botet; F Sánchez-Madrid
Journal:  J Cell Biol       Date:  2000-06-12       Impact factor: 10.539

10.  Paired immunoglobulin-like receptor (PIR)-A is involved in activating mast cells through its association with Fc receptor gamma chain.

Authors:  A Maeda; M Kurosaki; T Kurosaki
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.